Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein.
Open Access
- 1 January 1992
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 175 (1) , 227-235
- https://doi.org/10.1084/jem.175.1.227
Abstract
The immunogenicity of a chimeric T/B cell peptide corresponding to antigenically characterized epitopes of the Chlamydia trachomatis major outer membrane protein (MOMP) was studied in mice to further define its potential use in the development of a subunit vaccine in preventing blinding trachoma in humans. The chimeric peptide, designated A8-VDI, corresponds to a conserved MOMP T helper (Th) cell epitope(s) (A8, residues 106-130) and serovar A VDI (residues 66-80), which contains the serovar-specific neutralizing epitope 71VAGLEK76. Mice immunized with peptide A8-VDI produced high-titered polyclonal IgG antibodies which recognized the VAGLEK-neutralizing epitope. Peptide A8-VDI primed A/J mice to produce high-titered serum-neutralizing antibodies in response to a secondary immunization with intact chlamydial elementary bodies (EBs). Peptide A8-VDI, but not peptide VDI alone, was immunogenic in six different inbred strains of mice disparate at H-2, indicating that the Th cell epitope(s) contained in the A8 portion of the chimera was recognized in the context of multiple major histocompatibility complex (MHC) haplotypes. An unexpected finding of this work was that different inbred strains of mice immunized with the chimeric peptide produced antibodies of differing fine specificities to the VDI portion of the chimera. Some mouse strains produced anti-VDI antibodies that did not recognize the VAGLEK-neutralizing epitope. The ability of mice to respond to the VAGLEK-neutralizing site was not dependent on MHC haplotype since mouse strains of the same H-2 haplotype produced anti-VDI antibodies of differing fine specificity.Keywords
This publication has 18 references indexed in Scilit:
- The major outer membrane protein nucleotide sequence ofChlamydia trachomatis, serovar ENucleic Acids Research, 1990
- Nucleotide sequence of the major outer membrane protein gene fromChlamydia trachomatisserovar HNucleic Acids Research, 1989
- Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.Proceedings of the National Academy of Sciences, 1988
- High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis.The Journal of Experimental Medicine, 1988
- Strategies for epitope analysis using peptide synthesisJournal of Immunological Methods, 1987
- Prediction of immunodominant helper T cell antigenic sites from the primary sequence.The Journal of Immunology, 1987
- Sequence analysis of the major outer membrane protein gene from Chlamydia trachomatis serovar L2Journal of Bacteriology, 1986
- Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis.1973
- Immunity to Chlamydial Infections of the Eye. VI. Homologous Neutralization of Trachoma Infectivity for the Owl Monkey Conjunctivae by Eye Secretions from Humans with TrachomaThe Journal of Infectious Diseases, 1973
- Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance.1965